Anakinra for the Treatment of Antisynthetase Syndrome: A Monocentric Case Series and a Systematic Literature Review

J Rheumatol. 2023 Jan;50(1):151-153. doi: 10.3899/jrheum.220213. Epub 2022 Sep 15.

Authors

Corrado Campochiaro^{1

2}, Nicola Farina^{3

2}, Giacomo De Luca^{3

2}, Giorgia Trignani², Alessandro Tomelleri^{3

2}, Marco Matucci-Cerinic^{3

4}, Lorenzo Dagna^{3

2}

Affiliations

¹ Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele, Milan; campochiaro.corrado@hsr.it.
² Vita-Salute San Raffaele University, Milan.
³ Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele, Milan.
⁴ Department of Rheumatology, University of Florence, Florence, Italy.

PMID: 36109081
DOI: 10.3899/jrheum.220213

No abstract available

Publication types

Systematic Review
Letter

MeSH terms

Humans
Interleukin 1 Receptor Antagonist Protein* / therapeutic use
Myositis* / drug therapy

Substances

Interleukin 1 Receptor Antagonist Protein

Supplementary concepts

Antisynthetase syndrome